Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.57 |
| ▸ | SRC | P12931 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.45 |
| ▸ | KLK8 | O60259 | 1/20 | 0.44 |
| ▸ | PLAU | P00749 | 1/20 | 0.44 |
| ▸ | KLK2 | P20151 | 1/20 | 0.44 |
| ▸ | KLK4 | Q9Y5K2 | 1/20 | 0.44 |
| ▸ | ANPEP | P15144 | 1/20 | 0.43 |
| ▸ | LAP3 | P28838 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7738532 | 0.88 | L3MBTL1 (0.50) | L3MBTL1SRCTDP1MEN1KMT2A | |
| SCHEMBL649963 | 0.88 | TSHR (0.52) | L3MBTL1SRCTDP1 | |
| SCHEMBL27770069 | 0.85 | L3MBTL1 (0.47) | L3MBTL1SRCTDP1BTN3A1KLK8 | |
| SCHEMBL777179 | 0.84 | L3MBTL1 (0.59) | L3MBTL1SRCTDP1MEN1KMT2A | |
| SCHEMBL27769884 | 0.83 | L3MBTL1 (0.46) | L3MBTL1SRCTDP1MEN1KMT2A | |
| SCHEMBL28382525 | 0.83 | TSHR (0.50) | L3MBTL1SRCMEN1KMT2AHTT | |
| SCHEMBL4454035 | 0.83 | L3MBTL1 (0.53) | L3MBTL1SRCTDP1MEN1KMT2A | |
| SCHEMBL13430953 | 0.82 | LTA4H (0.47) | L3MBTL1 | |
| SCHEMBL28056075 | 0.82 | L3MBTL1 (0.45) | L3MBTL1SRCTDP1MEN1KMT2A | |
| SCHEMBL5617330 | 0.81 | SRC (0.56) | L3MBTL1SRCTDP1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114524843-A | Hydroxyl-terminated reactive flame retardant and preparation method thereof | 青岛长荣化工科技有限公司 | 2022-05-24 | — | — | CN | claimed |
| CN-101205268-B | Method for hydrogenating conjugated diene polymer and hydrogenation catalyst composition | TSRC CORP | 2010-09-29 | — | — | CN | claimed |
| CN-101205268-A | Method for hydrogenating conjugated diene polymer and hydrogenation catalyst composition | TSRC CORP (CN) | 2008-06-25 | — | — | CN | claimed |
| EP-0624162-B1 | NOVEL STEROID INTERMEDIATES AND PROCESSES FOR THEIR PREPARATION | SCHERING CORP (US) | 1998-09-16 | — | — | EP | claimed |
| JP-62230796-A | — | — | None | — | — | JP | disclosed |
| US-12100809-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-24 | — | — | US | disclosed |
| US-20230071620-A1 | PHARMACEUTICAL COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS | ACHILLION PHARMACEUTICALS, INC. | 2023-03-09 | — | — | US | disclosed |
| CN-114524843-A | Hydroxyl-terminated reactive flame retardant and preparation method thereof | 青岛长荣化工科技有限公司 | 2022-05-24 | — | — | CN | disclosed |
| US-20220149436-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-05-12 | — | — | US | disclosed |
| US-20220127533-A1 | PHOSPHORUS NITROGEN FLAME RETARDANT, METHOD THEREOF AND MATERIAL COMPRISING THE SAME | ZHOU CHONGFU (US) | 2022-04-28 | — | — | US | disclosed |
| US-11283107-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-03-22 | — | — | US | disclosed |
| CN-107709404-B | Polycarbonate resin and method for producing same | 乐天尖端材料株式会社 | 2020-04-07 | — | — | CN | disclosed |
| US-4381390-A | Thermoplastic polyphosphonatophenyl ester carbonate from aryloxycarbonyloxy-benzoic acid aryl ester and preparation thereof | MOBAY CHEMICAL CORPORATION (US) | 1983-04-26 | — | — | US | disclosed |
| US-4377537-A | FROM TRIARYL PHOSPHITE AND ALKYL PHOSPHITE OR PHOSPHONOUS ACID DIARYL ESTER AND PHOSPHONOUS ACID DIALKYL ESTER | BAYER AKTIENGESELLSCHAFT (DE) | 1983-03-22 | — | — | US | disclosed |
| EP-0061640-A1 | Process for the preparation of thermoplastic aromatic polyphosphonates containing small quantities of carbonate structures | BAYER AG (DE) | 1982-10-06 | — | — | EP | disclosed |
| US-4322520-A | Aromatic thermoplastic polyphosphonatocarbonate | BAYER AKTIENGESELLSCHAFT (DE) | 1982-03-30 | — | — | US | disclosed |
| EP-0033826-A1 | Thermoplastic aromatic polyphosphonate carbonates with thermal resistance to ageing, their preparation and their use | BAYER AG (DE) | 1981-08-19 | — | — | EP | disclosed |
| US-4233182-A | High activity catalyst for the polymerization of alpha-olefins | STANDARD OIL COMPANY (INDIANA) (US) | 1980-11-11 | — | — | US | disclosed |
| US-4233253-A | Method for the preparation of metal salts of phosphorus acid esters | STANDARD OIL COMPANY (INDIANA) (US) | 1980-11-11 | — | — | US | disclosed |
| EP-0013744-A1 | Catalyst and process for the polymerization of alpha-olefins and a process for preparing an alpha-olefin polymerization catalyst component | Standard Oil Company (US) | 1980-08-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230071620-A1 | PHARMACEUTICAL COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS | CFD, TFPI, CFH | L3MBTL1 4825/4885SRC 2406/4885TDP1 4456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.